Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | voltage-gated potassium channel | 0.0083 | 0.4066 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.3682 | 0.3682 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0021 | 0.0344 | 0.0847 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0021 | 0.0344 | 0.0344 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0021 | 0.0344 | 0.5 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.005 | 0.2095 | 0.2095 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.2095 | 0.5153 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0021 | 0.0344 | 0.0847 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.3682 | 0.3682 |
Echinococcus multilocularis | potassium voltage gated channel protein | 0.0083 | 0.4066 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.0021 | 0.0344 | 0.5 |
Echinococcus multilocularis | potassium voltage gated channel subfamily A | 0.0079 | 0.385 | 0.9469 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0021 | 0.0344 | 0.0344 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3682 | 0.9055 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.3682 | 0.3682 |
Echinococcus granulosus | potassium voltage gated channel subfamily A | 0.0083 | 0.4066 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0021 | 0.0344 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.2095 | 0.5153 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0021 | 0.0344 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.2095 | 0.5153 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0.0344 | 0.5 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0021 | 0.0344 | 0.5 |
Schistosoma mansoni | ap endonuclease | 0.0021 | 0.0344 | 0.0847 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.005 | 0.2095 | 0.2095 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3682 | 0.9055 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.2095 | 0.5153 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.3682 | 0.9055 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.3682 | 0.3682 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.3682 | 0.9055 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0021 | 0.0344 | 0.5 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0021 | 0.0344 | 0.5 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0021 | 0.0344 | 0.5 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0021 | 0.0344 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3682 | 0.9055 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.3682 | 0.3682 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0083 | 0.4066 | 1 |
Echinococcus granulosus | potassium voltage gated channel protein | 0.0083 | 0.4066 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.2095 | 0.5153 |
Schistosoma mansoni | ap endonuclease | 0.0021 | 0.0344 | 0.0847 |
Brugia malayi | Voltage-gated potassium channel, Shaker-family (KCNA, Kv1-like) alpha-subunit | 0.0083 | 0.4066 | 0.4066 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0021 | 0.0344 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.2095 | 0.5153 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.2095 | 0.5153 |
Brugia malayi | RNA binding protein | 0.0076 | 0.3682 | 0.3682 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3682 | 0.9055 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3682 | 0.9055 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.0344 | 0.5 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0021 | 0.0344 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.4066 | 0.4066 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0021 | 0.0344 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0182 | 1 | 1 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0021 | 0.0344 | 0.5 |
Onchocerca volvulus | 0.0182 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.6169 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 3.2944 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Potency (functional) | = 112.2018 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.